A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention-Reference-Cited by-同舟云学术

A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention

Published:2008-12-01 Issue:7 Volume:72 Page:958-965
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Nie Bin,Cheng Wan-Jun,Li Yan-Fang,Cao Zheng,Yang Qing,Zhao Ying-Xin,Guo Yong-He,Zhou Yu-Jie

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Reference24 articles.

1. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention;Rihal;Circulation,2002

2. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography;Manske;Am J Med,1990

3. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. The iohexol cooperative study;Rudnick;Kidney Int,1995

4. Hospital-acquired renal insufficiency;Nash;Am J Kidney Dis,2002

5. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality;McCullough;Am J Med,1997

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Iodixanol in Computed Coronary Tomographic Angiography and Cardiac Catheterization;Journal of Cardiovascular Development and Disease;2023-10-31

2. Safety asssessment of iopromide contrast media: a narrative review focusing on adverse events;Current Issues in Pharmacy and Medical Sciences;2023-09-01

3. Contrast Induced Encephalopathy: a rare complication in a patient on Peritoneal Dialysis with several risk factors;Nephron;2023-07-13

4. Incidence of Major Adverse Cardiovascular and Cerebrovascular Events in Chinese Patients Undergoing Percutaneous Coronary Intervention with Iodixanol: An Observational Postauthorization Study;Cardiology Discovery;2023-06

5. Neutrophil gelatinase-associated lipocalin monitoring reveals persistent subclinical kidney injury following intraarterial administration of iodinated contrast agents;Scientific Reports;2022-11-14